Twenty - First Century Pharmaceutical Development (Record no. 16363)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01755nam a2200169Ia 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 140223b2004 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781574911022 |
| Terms of availability | 0.00 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615 |
| Item number | TWE |
| 245 ## - TITLE STATEMENT | |
| Title | Twenty - First Century Pharmaceutical Development |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Colorado |
| Name of publisher, distributor, etc | Interpharm Press |
| Date of publication, distribution, etc | 2004 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 388p |
| 500 ## - GENERAL NOTE | |
| General note | Organized according to the functional disciplines involved in the development of drugs, Twenty-First Century Pharmaceutical Development provides an overview of the key aspects of the current drug development process and possibilities for the future. The book covers financial strategies for small drug developers, managing basic research, protecting intellectual property, marketing, regulatory issues, preclinical toxicology studies, drug product formulation development, manufacturing, developing a clinical strategy, the role of statistics, project management, outsourcing, diagnostics, medical devices, and more. supportive endpoints, reimbursement planning, clinical proposal, preformulation activities, healthcare buyers, finished device manufacturer, preliminary market analysis, liquid oral preparations, preclinical toxicology studies, discovery continuum, formulation scientist, tablet core, dosage form development, solid oral dosage forms, dry granulation, quality system audits, clinical supplies, protein therapeutics, pharmaceutical dosage forms, pharmaceutical development, outsourcing providers, drug developers, toxic stimuli, longitude problem, diagnostic products |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pharmaceutical Development |
| 9 (RLIN) | 18082 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blaisdell, Peter |
| Relator term | Editor |
| 9 (RLIN) | 18620 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Item type | Book |
| Call number prefix | 615 |
| Call number suffix | TWE |
| 995 ## - RECOMMENDATION 995 [LOCAL, UNIMARC FRANCE] | |
| Origin of item (home branch) (free text) | Pharmacy Reference |
| Genre | P0005785 |
| Section | 615 |
| Recipient parent organisation code | P0005785 |
No items available.